Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity.

Tao Y, Han J, Wang X, Dou H.

Colloids Surf B Biointerfaces. 2013 Feb 1;102:604-10. doi: 10.1016/j.colsurfb.2012.08.062. Epub 2012 Sep 6.

PMID:
23104031
2.

Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors.

Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X.

Biomaterials. 2011 Apr;32(11):2894-906. doi: 10.1016/j.biomaterials.2010.12.039. Epub 2011 Jan 21.

PMID:
21256584
3.

Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.

Zhang Y, Huang Y, Zhao W, Lu J, Zhang P, Zhang X, Li J, Gao X, Venkataramanan R, Li S.

AAPS J. 2014 Nov;16(6):1282-91. doi: 10.1208/s12248-014-9651-2. Epub 2014 Sep 6.

4.

Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.

Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X.

Int J Pharm. 2009 Jul 6;376(1-2):176-85. doi: 10.1016/j.ijpharm.2009.04.030. Epub 2009 May 3.

PMID:
19409463
5.

Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.

Lian H, Sun J, Yu YP, Liu YH, Cao W, Wang YJ, Sun YH, Wang SL, He ZG.

Int J Nanomedicine. 2011;6:3323-34. doi: 10.2147/IJN.S26305. Epub 2011 Dec 12.

6.

Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.

Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J, Sha X, Fang X.

Eur J Pharm Biopharm. 2010 Aug;75(3):341-53. doi: 10.1016/j.ejpb.2010.04.017. Epub 2010 May 6.

PMID:
20451605
7.

[Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].

Wang YZ, Fang XL, Li YJ, Zhang ZW, Han LM, Sha XY.

Yao Xue Xue Bao. 2008 Jun;43(6):640-6. Chinese.

PMID:
18822969
8.

Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.

Wang Y, Hao J, Li Y, Zhang Z, Sha X, Han L, Fang X.

Biomaterials. 2012 Jun;33(18):4741-51. doi: 10.1016/j.biomaterials.2012.03.013. Epub 2012 Mar 23.

PMID:
22445254
9.

Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.

Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE.

J Control Release. 2005 Mar 21;103(2):341-53.

PMID:
15763618
10.

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Gong C, Xie Y, Wu Q, Wang Y, Deng S, Xiong D, Liu L, Xiang M, Qian Z, Wei Y.

Nanoscale. 2012 Sep 28;4(19):6004-17. doi: 10.1039/c2nr31517c. Epub 2012 Aug 22.

PMID:
22910790
11.

Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.

Wang F, Shen Y, Xu X, Lv L, Li Y, Liu J, Li M, Guo A, Guo S, Jin F.

Int J Pharm. 2013 Nov 1;456(1):101-12. doi: 10.1016/j.ijpharm.2013.08.008. Epub 2013 Aug 19.

PMID:
23968782
13.

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.

Wang Y, Li Y, Zhang L, Fang X.

Arch Pharm Res. 2008 Apr;31(4):530-8. doi: 10.1007/s12272-001-1189-2. Epub 2008 May 1.

PMID:
18449513
14.

The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.

Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X.

Biomaterials. 2011 Sep;32(25):5934-44. doi: 10.1016/j.biomaterials.2011.04.075. Epub 2011 May 18.

PMID:
21596432
15.
16.

The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.

Zhao BJ, Ke XY, Huang Y, Chen XM, Zhao X, Zhao BX, Lu WL, Lou JN, Zhang X, Zhang Q.

J Drug Target. 2011 Jun;19(5):382-90. doi: 10.3109/1061186X.2010.504267. Epub 2010 Aug 2.

PMID:
20677914
17.

Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.

Zhang L, He Y, Ma G, Song C, Sun H.

Nanomedicine. 2012 Aug;8(6):925-34. doi: 10.1016/j.nano.2011.11.005. Epub 2011 Nov 17.

PMID:
22101107
18.

In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.

Liang N, Sun S, Hong J, Tian J, Fang L, Cui F.

Drug Deliv. 2015 Jul 14:1-10. [Epub ahead of print]

PMID:
26165423
19.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
20.

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.

Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z.

Int J Pharm. 2011 Dec 12;421(1):160-9. doi: 10.1016/j.ijpharm.2011.09.006. Epub 2011 Sep 16.

PMID:
21945183
Items per page

Supplemental Content

Write to the Help Desk